Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in SLE (BLISS-52)
NCT00424476Phase 3Completed
- Sponsor
- Human Genome Sciences
- Start
- May 2007
- Primary completion
- May 2009
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 3 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by Human Genome Sciences. Started May 2007; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00424476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424476.